Last updated on September 2018

Efficacy and Safety of COMBIGAN in Korean Patients With Primary Open Angle Glaucoma (POAG) and Normal Tension Glaucoma (NTG)


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Open-Angle | Glaucoma | Normal Tension Glaucoma
  • Age: Between 18 - 100 Years
  • Gender: Male or Female
  • Other:
    Patients with Primary open angle glaucoma (Regardless of Intraocular pressure)
    Previous history of topical beta-blocker use and insufficiently controlled IOP

You may not be eligible for this study if the following are true:

  • Pigmentary or exfoliative glaucoma
    History of angle-closure or an occludable angle by gonioscopy
    Prior filtration or laser iridotomy
    Argon laser trabeculoplasty or Selective laser trabeculoplasty performed less than 6
    months
    History or signs of chronic inflammatory eye disease, ocular trauma, or potentially
    progressive retinal disease

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.